MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 3 filers reported holding MYOVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $171 | -99.8% | 29,559 | +26.3% | 0.01% | +180.0% |
| Q3 2022 | $74,000 | +146.7% | 23,402 | +64.0% | 0.01% | +150.0% |
| Q2 2022 | $30,000 | -68.8% | 14,273 | -22.3% | 0.00% | -60.0% |
| Q1 2022 | $96,000 | +4700.0% | 18,375 | +18275.0% | 0.01% | – |
| Q3 2021 | $2,000 | -77.8% | 100 | -75.0% | 0.00% | – |
| Q2 2021 | $9,000 | – | 400 | -87.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 3,300 | -62.7% | 0.00% | -100.0% |
| Q4 2020 | $84,000 | +15.1% | 8,844 | -52.8% | 0.00% | 0.0% |
| Q3 2020 | $73,000 | +92.1% | 18,744 | +83.8% | 0.00% | +100.0% |
| Q2 2020 | $38,000 | +22.6% | 10,200 | -13.6% | 0.00% | +100.0% |
| Q1 2020 | $31,000 | -24.4% | 11,800 | -0.8% | 0.00% | -66.7% |
| Q4 2019 | $41,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |